SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.29 |
| Enterprise Value ($M) | 144.08 |
| Book Value ($M) | -131.19 |
| Book Value / Share | -2.41 |
| Price / Book | -0.09 |
| NCAV ($M) | -135.70 |
| NCAV / Share | -2.49 |
| Price / NCAV | -0.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.80 |
| Return on Assets (ROA) | -0.99 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.36 |
| Current Ratio | 4.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.63 |
| Assets | 26.14 |
| Liabilities | 157.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -46.95 |
| Net Income | -59.08 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -44.85 |
| Cash from Investing | 27.29 |
| Cash from Financing | 31.50 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | ALPHA PHARMA Investments LLC | 5.06 | ||
| 13G/A | Altamont Phamaceutical Holdings, Llc | 0.00 | -100.00 | |
| 13D/A | Sofinnova Venture Partners IX, L.P. | 0.00 | -100.00 | |
| 13G/A | Sectoral Asset Management Inc | 0.00 | -100.00 | |
| 13G | Schneid Yair | 13.07 | 0.00 | |
| 13G | Gsa Capital Partners Llp | 7.16 | ||
| 13D/A | Blackstone Holdings I/II GP L.L.C. | 4.20 | 0.66 | |
| 13G/A | Novo Holdings A/S | 4.90 | -14.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 726,528 | 1,914,906 | 37.94 | |
| 158,802 | 640,425 | 24.80 | |
| 95,826 | 811,664 | 11.81 | |
| 40,571 | 44,583 | 91.00 | |
| 63,377 | 113,576 | 55.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GANX – Gain Therapeutics, Inc. | GHRS – GH Research PLC |
| GLYC – GlycoMimetics, Inc. | HCWB – HCW Biologics Inc. |
| HRMY – Harmony Biosciences Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io